Your search returned 3 results.

Results
	1.	Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials. MedStar authors: Weissman, Neil J PMID: 27888609 Year: 2017 Citation: Obesity. 25(1):39-44, 2017 Jan Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Fain R, Hall N, Shanahan WR, Smith SR, Weissman NJ DOI: https://dx.doi.org/10.1002/oby.21695 Add to cart (remove)
	2.	Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors: Weissman, Neil J PMID: 22421927 Year: 2012 Citation: Obesity. 20(7):1426-36, 2012 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J DOI: http://dx.doi.org/10.1038/oby.2012.66 Add to cart (remove)
	3.	Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials. MedStar authors: Weissman, Neil J PMID: 23661689 Year: 2013 Citation: Circulation. Cardiovascular imaging. 6(4):560-7, 2013 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Anderson CM, Koch GG, Sanchez M, Shanahan WR, Smith SR, Weissman NJ DOI: http://dx.doi.org/10.1161/CIRCIMAGING.112.000128 Add to cart (remove)

Powered by Koha